甲状腺激素敏感性受损与亚临床甲状腺功能减退症患者的高尿酸血症、肥胖及心血管疾病风险相关
研究纳入11,109例亚临床甲状腺功能减退症(SCH)患者,计算甲状腺激素敏感性指标(TFQI、TSHI、TT4RI)。结果显示,甲状腺激素中枢敏感性降低与高尿酸血症(HUA)和心血管疾病(CVD)风险升高相关,与肥胖风险降低相关。这些发现可能有助于理解SCH中甲状腺激素敏感性与代谢疾病的相互作用。
核心结论
- SCH患者甲状腺激素敏感性受损与高尿酸血症和心血管疾病风险升高相关,与肥胖风险降低相关。
研究设计与样本
- 研究纳入11,109例SCH患者,所有患者TSH水平>4.2 mIU/L且游离甲状腺素(fT4)正常(12.0-22.0 pmol/L)。
- 计算甲状腺激素敏感性指标TFQI、TSHI和TT4RI,并分析其与代谢指标及CVD风险的关系。
主要发现
- 甲状腺激素中枢敏感性降低的参与者BMI较低且血清尿酸(sUA)水平较高。
- 在分析HbA1C、HUA和CVD风险时进一步调整BMI,结果相似;TSHI和TT4RI也得出相似结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Subclinical hypothyroidism (SCH) is associated with an increased risk of metabolic disorders and cardiovascular events. There is a delicate interplay between thyroid hormones and thyrotropin (TSH) and metabolic homeostasis. However, the association between thyroid hormone sensitivity and metabolic indices has not been elucidated in SCH. Methods: We enrolled 11,109 participants with SCH. All participants had a TSH level >4.2 mIU/L and normal free thyroxine (fT4; 12.0-22.0 pmol/L). Metabolic indices (body mass index [BMI], blood pressure, serum lipid, serum uric acid [sUA], plasma glucose and glycosylated hemoglobin [HbA1C]) were measured. The thyroid hormone sensitivity indices that include thyroid feedback quantile-based index (TFQI), TSH index (TSHI), and thyrotroph thyroxine resistance index (TT4RI) were calculated based on fT4 and TSH. Higher TFQI quartiles indicated lower thyroid hormone sensitivity. The relationship between thyroid hormone sensitivity indices and metabolic indices and cardiovascular disease (CVD) risk were calculated. Results: Participants with decreased central sensitivity to thyroid hormone had lower BMI and higher sUA levels. The odds ratio of the fourth versus the first quartile of TFQI was 0.85 [confidence interval, CI: 0.73-0.96] for obesity, 1.64 [CI: 1.37-1.92] for hyperuricemia (HUA), and 12.22 [CI: 5.32-28.07] for 10-year risk distribution for CVD >20%. Further adjustment for BMI when analyzing HbA1C, HUA, and CVD risk generated similar results. TSHI and TT4RI also yielded similar results. Conclusions: Impaired sensitivity to thyroid hormone in SCH is associated with higher risk of HUA and CVD and lower risk of obesity. These findings are potentially useful for understanding the interaction between thyroid hormone sensitivity and metabolic diseases in SCH.
引用
- Sun Y, Teng D, Zhao L, et al. Impaired Sensitivity to Thyroid Hormones Is Associated with Hyperuricemia, Obesity, and Cardiovascular Disease Risk in Subjects with Subclinical Hypothyroidism. Thyroid. 2022. PMID: 35078326. doi:10.1089/thy.2021.0500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。